Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PROCEPT BioRobotics Corporation PRCT
$29.69
+$0.21 (0.71%)
На 18:04, 12 мая 2023
+65.04%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
1266941444.00000000
-
week52high
52.40
-
week52low
25.29
-
Revenue
75014000
-
P/E TTM
-13
-
Beta
0.00000000
-
EPS
-2.30000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 10:59
Описание компании
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Keybanc | Overweight | 15 июл 2022 г. | |
| SVB Leerink | Outperform | Outperform | 09 мар 2022 г. |
| B of A Securities | Buy | Buy | 09 мар 2022 г. |
| SVB Leerink | Outperform | Outperform | 05 ноя 2021 г. |
| Guggenheim | Buy | 11 окт 2021 г. | |
| Wells Fargo | Overweight | 02 сент 2022 г. | |
| Truist Securities | Buy | 25 окт 2022 г. | |
| BTIG | Neutral | 31 окт 2022 г. | |
| Keybanc | Overweight | Overweight | 04 ноя 2022 г. |
| Goldman Sachs | Neutral | Neutral | 04 ноя 2022 г. |
| Wells Fargo | Overweight | Overweight | 12 дек 2022 г. |
| Wells Fargo | Overweight | Overweight | 12 янв 2023 г. |
| Truist Securities | Buy | Buy | 31 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Shiblaq Hisham | D | 27275 | 466 | 04 янв 2023 г. |
| Shiblaq Hisham | D | 27741 | 6306 | 03 янв 2023 г. |
| Shiblaq Hisham | D | 34047 | 5421 | 03 янв 2023 г. |
| Shiblaq Hisham | D | 39468 | 9736 | 03 янв 2023 г. |
| Nouri Alaleh | D | 4062 | 1588 | 27 дек 2022 г. |
| Nouri Alaleh | D | 5650 | 1476 | 27 дек 2022 г. |
| Nouri Alaleh | D | 7126 | 11489 | 19 дек 2022 г. |
| Nouri Alaleh | D | 18615 | 8511 | 19 дек 2022 г. |
| Nouri Alaleh | D | 27126 | 20000 | 16 дек 2022 г. |
| Desai Antal Rohit | D | 5029869 | 1726534 | 05 дек 2022 г. |
Новостная лента
PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
14 дек 2022 г. в 16:05
REDWOOD CITY, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Tuesday, January 10 at 9:45 a.m. Pacific Time. A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the company's website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.
Procept BioRobotics: Aquablation System Meaningful Insulator
Seeking Alpha
18 ноя 2022 г. в 16:20
PROCEPT BioRobotics Corporation reported 135% YoY Q3 revenue growth to $20.3mm. Growth was underscored by robotic system sales and utilization from current placements.
PROCEPT BioRobotics Corporation (PRCT) Q3 2022 Earnings Call Transcript
Seeking Alpha
06 ноя 2022 г. в 08:22
PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q3 2022 Earnings Call Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Bacso – Vice President-Investor Relations Reza Zadno – Chief Executive Officer Kevin Waters – Senior Vice President and Chief Financial Office Conference Call Participants Craig Bijou – BofA Securities Nathan Treybeck – Wells Fargo Richard Newitter – Truist Securities Ryan Zimmerman – BTIG Neil Chatterji – B. Riley Matthew Mishan – KeyBanc Philip Coover – Goldman Sachs Joshua Jennings – Cowen Operator Good day.
PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
03 ноя 2022 г. в 19:36
PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -8.51% and 17.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
Investors Business Daily
05 окт 2022 г. в 13:18
Biotech isn't the only place investors in health care stocks can make money in 2022. Take a look at leading medical-equipment stocks.